COVID-19 monoclonal antibodies reduce risk of hospitalization and death

EurekAlert! | Dec 13, 2021 at 1:00 AM
  • The results were less pronounced in younger populations, but overall, more positive results were seen in those who received monoclonal antibody infusions than in those who did not.
  • The School of Medicine is the academic partner of UPMC.